Pfizer Wins Appeal Over Neurontin
Pfizer Inc. has promised to seek "full compensation" against generic drug manufacturers after a U.S. appellate court resuscitated Pfizer's patent infringement suit over its blockbuster epilepsy drug Neurontin, which had earned...To view the full article, register now.
Already a subscriber? Click here to view full article